Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

The document concludes that accurate diagnosis of hair disorders is crucial and requires a range of diagnostic methods.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

AGA can occur in children with family history; early diagnosis and treatment important.

S100A4 and S100A6 proteins may activate stem cells for hair follicle regeneration and could be potential targets for hair loss treatments.

Electrospun nanofibers show promise for enhancing blood vessel growth in tissue engineering but need further research to improve their effectiveness.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Vitamin D3 affects cell differentiation in specific skin areas.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

Some breast cancer chemotherapy can cause permanent hair loss.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Some chemotherapy can cause permanent hair loss.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The document concludes that good cosmetic outcomes in hair transplantation depend on the surgeon's artistic skill and careful planning.

Minoxidil helps hair growth and prevents hair loss in androgenetic alopecia. It's safe and effective.

Platelet preparations generally show positive effects on wound healing and facial rejuvenation, but more thorough research is needed to confirm their effectiveness.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Using dermoscopy to guide scalp biopsies is an effective way to diagnose cicatricial alopecia.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Hedgehog signaling helps keep hair follicle stem cells the same in both young and old human skin.

Sebaceous glands in the skin play a key role in absorbing the antiandrogen drug RU 58841, especially when it's encapsulated in liposomes.